Sun Pharma commences Tender Offer for acquisition of InSite Vision

For $0.35 per share in cash

Sun Pharmaceutical Industries announced that it has commenced a tender offer through its indirect wholly owned subsidiary, Thea Acquisition Corporation, for all the outstanding shares of common stock of InSite Vision Incorporated for $0.35 per share in cash, without interest and less any required withholding taxes.

Powered by Capital Market - Live News